
The global Bionic Exoskeletons market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Bionic Exoskeletons is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Bionic Exoskeletons is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Bionic Exoskeletons is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Bionic Exoskeletons players cover Ekso Bionics, Ottobock Inc, DJO Global Inc., Ossur Corporate, Rex Bionics Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The “Bionic Exoskeletons Industry Forecast” looks at past sales and reviews total world Bionic Exoskeletons sales in 2024, providing a comprehensive analysis by region and market sector of projected Bionic Exoskeletons sales for 2025 through 2031. With Bionic Exoskeletons sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bionic Exoskeletons industry.
This Insight Report provides a comprehensive analysis of the global Bionic Exoskeletons landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bionic Exoskeletons portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bionic Exoskeletons market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bionic Exoskeletons and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bionic Exoskeletons.
This report presents a comprehensive overview, market shares, and growth opportunities of Bionic Exoskeletons market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Active Exoskeletons
Passive Exoskeletons
Segmentation by Application:
Medical
Military
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Ekso Bionics
Ottobock Inc
DJO Global Inc.
Ossur Corporate
Rex Bionics Ltd.
Alter G
ReWalk Robotics
Axosuits
EduExo
Festo
Lockheed Martin
BAE Systems
Raytheon
General Dynamics
Honeywell
Bionic Power
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bionic Exoskeletons market?
What factors are driving Bionic Exoskeletons market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bionic Exoskeletons market opportunities vary by end market size?
How does Bionic Exoskeletons break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bionic Exoskeletons Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bionic Exoskeletons by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bionic Exoskeletons by Country/Region, 2020, 2024 & 2031
2.2 Bionic Exoskeletons Segment by Type
2.2.1 Active Exoskeletons
2.2.2 Passive Exoskeletons
2.3 Bionic Exoskeletons Sales by Type
2.3.1 Global Bionic Exoskeletons Sales Market Share by Type (2020-2025)
2.3.2 Global Bionic Exoskeletons Revenue and Market Share by Type (2020-2025)
2.3.3 Global Bionic Exoskeletons Sale Price by Type (2020-2025)
2.4 Bionic Exoskeletons Segment by Application
2.4.1 Medical
2.4.2 Military
2.5 Bionic Exoskeletons Sales by Application
2.5.1 Global Bionic Exoskeletons Sale Market Share by Application (2020-2025)
2.5.2 Global Bionic Exoskeletons Revenue and Market Share by Application (2020-2025)
2.5.3 Global Bionic Exoskeletons Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Bionic Exoskeletons Breakdown Data by Company
3.1.1 Global Bionic Exoskeletons Annual Sales by Company (2020-2025)
3.1.2 Global Bionic Exoskeletons Sales Market Share by Company (2020-2025)
3.2 Global Bionic Exoskeletons Annual Revenue by Company (2020-2025)
3.2.1 Global Bionic Exoskeletons Revenue by Company (2020-2025)
3.2.2 Global Bionic Exoskeletons Revenue Market Share by Company (2020-2025)
3.3 Global Bionic Exoskeletons Sale Price by Company
3.4 Key Manufacturers Bionic Exoskeletons Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bionic Exoskeletons Product Location Distribution
3.4.2 Players Bionic Exoskeletons Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Bionic Exoskeletons by Geographic Region
4.1 World Historic Bionic Exoskeletons Market Size by Geographic Region (2020-2025)
4.1.1 Global Bionic Exoskeletons Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bionic Exoskeletons Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bionic Exoskeletons Market Size by Country/Region (2020-2025)
4.2.1 Global Bionic Exoskeletons Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bionic Exoskeletons Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bionic Exoskeletons Sales Growth
4.4 APAC Bionic Exoskeletons Sales Growth
4.5 Europe Bionic Exoskeletons Sales Growth
4.6 Middle East & Africa Bionic Exoskeletons Sales Growth
5 Americas
5.1 Americas Bionic Exoskeletons Sales by Country
5.1.1 Americas Bionic Exoskeletons Sales by Country (2020-2025)
5.1.2 Americas Bionic Exoskeletons Revenue by Country (2020-2025)
5.2 Americas Bionic Exoskeletons Sales by Type (2020-2025)
5.3 Americas Bionic Exoskeletons Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bionic Exoskeletons Sales by Region
6.1.1 APAC Bionic Exoskeletons Sales by Region (2020-2025)
6.1.2 APAC Bionic Exoskeletons Revenue by Region (2020-2025)
6.2 APAC Bionic Exoskeletons Sales by Type (2020-2025)
6.3 APAC Bionic Exoskeletons Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bionic Exoskeletons by Country
7.1.1 Europe Bionic Exoskeletons Sales by Country (2020-2025)
7.1.2 Europe Bionic Exoskeletons Revenue by Country (2020-2025)
7.2 Europe Bionic Exoskeletons Sales by Type (2020-2025)
7.3 Europe Bionic Exoskeletons Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bionic Exoskeletons by Country
8.1.1 Middle East & Africa Bionic Exoskeletons Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bionic Exoskeletons Revenue by Country (2020-2025)
8.2 Middle East & Africa Bionic Exoskeletons Sales by Type (2020-2025)
8.3 Middle East & Africa Bionic Exoskeletons Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bionic Exoskeletons
10.3 Manufacturing Process Analysis of Bionic Exoskeletons
10.4 Industry Chain Structure of Bionic Exoskeletons
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bionic Exoskeletons Distributors
11.3 Bionic Exoskeletons Customer
12 World Forecast Review for Bionic Exoskeletons by Geographic Region
12.1 Global Bionic Exoskeletons Market Size Forecast by Region
12.1.1 Global Bionic Exoskeletons Forecast by Region (2026-2031)
12.1.2 Global Bionic Exoskeletons Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bionic Exoskeletons Forecast by Type (2026-2031)
12.7 Global Bionic Exoskeletons Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Ekso Bionics
13.1.1 Ekso Bionics Company Information
13.1.2 Ekso Bionics Bionic Exoskeletons Product Portfolios and Specifications
13.1.3 Ekso Bionics Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Ekso Bionics Main Business Overview
13.1.5 Ekso Bionics Latest Developments
13.2 Ottobock Inc
13.2.1 Ottobock Inc Company Information
13.2.2 Ottobock Inc Bionic Exoskeletons Product Portfolios and Specifications
13.2.3 Ottobock Inc Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Ottobock Inc Main Business Overview
13.2.5 Ottobock Inc Latest Developments
13.3 DJO Global Inc.
13.3.1 DJO Global Inc. Company Information
13.3.2 DJO Global Inc. Bionic Exoskeletons Product Portfolios and Specifications
13.3.3 DJO Global Inc. Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 DJO Global Inc. Main Business Overview
13.3.5 DJO Global Inc. Latest Developments
13.4 Ossur Corporate
13.4.1 Ossur Corporate Company Information
13.4.2 Ossur Corporate Bionic Exoskeletons Product Portfolios and Specifications
13.4.3 Ossur Corporate Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ossur Corporate Main Business Overview
13.4.5 Ossur Corporate Latest Developments
13.5 Rex Bionics Ltd.
13.5.1 Rex Bionics Ltd. Company Information
13.5.2 Rex Bionics Ltd. Bionic Exoskeletons Product Portfolios and Specifications
13.5.3 Rex Bionics Ltd. Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Rex Bionics Ltd. Main Business Overview
13.5.5 Rex Bionics Ltd. Latest Developments
13.6 Alter G
13.6.1 Alter G Company Information
13.6.2 Alter G Bionic Exoskeletons Product Portfolios and Specifications
13.6.3 Alter G Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Alter G Main Business Overview
13.6.5 Alter G Latest Developments
13.7 ReWalk Robotics
13.7.1 ReWalk Robotics Company Information
13.7.2 ReWalk Robotics Bionic Exoskeletons Product Portfolios and Specifications
13.7.3 ReWalk Robotics Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 ReWalk Robotics Main Business Overview
13.7.5 ReWalk Robotics Latest Developments
13.8 Axosuits
13.8.1 Axosuits Company Information
13.8.2 Axosuits Bionic Exoskeletons Product Portfolios and Specifications
13.8.3 Axosuits Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Axosuits Main Business Overview
13.8.5 Axosuits Latest Developments
13.9 EduExo
13.9.1 EduExo Company Information
13.9.2 EduExo Bionic Exoskeletons Product Portfolios and Specifications
13.9.3 EduExo Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 EduExo Main Business Overview
13.9.5 EduExo Latest Developments
13.10 Festo
13.10.1 Festo Company Information
13.10.2 Festo Bionic Exoskeletons Product Portfolios and Specifications
13.10.3 Festo Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Festo Main Business Overview
13.10.5 Festo Latest Developments
13.11 Lockheed Martin
13.11.1 Lockheed Martin Company Information
13.11.2 Lockheed Martin Bionic Exoskeletons Product Portfolios and Specifications
13.11.3 Lockheed Martin Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Lockheed Martin Main Business Overview
13.11.5 Lockheed Martin Latest Developments
13.12 BAE Systems
13.12.1 BAE Systems Company Information
13.12.2 BAE Systems Bionic Exoskeletons Product Portfolios and Specifications
13.12.3 BAE Systems Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 BAE Systems Main Business Overview
13.12.5 BAE Systems Latest Developments
13.13 Raytheon
13.13.1 Raytheon Company Information
13.13.2 Raytheon Bionic Exoskeletons Product Portfolios and Specifications
13.13.3 Raytheon Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Raytheon Main Business Overview
13.13.5 Raytheon Latest Developments
13.14 General Dynamics
13.14.1 General Dynamics Company Information
13.14.2 General Dynamics Bionic Exoskeletons Product Portfolios and Specifications
13.14.3 General Dynamics Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 General Dynamics Main Business Overview
13.14.5 General Dynamics Latest Developments
13.15 Honeywell
13.15.1 Honeywell Company Information
13.15.2 Honeywell Bionic Exoskeletons Product Portfolios and Specifications
13.15.3 Honeywell Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Honeywell Main Business Overview
13.15.5 Honeywell Latest Developments
13.16 Bionic Power
13.16.1 Bionic Power Company Information
13.16.2 Bionic Power Bionic Exoskeletons Product Portfolios and Specifications
13.16.3 Bionic Power Bionic Exoskeletons Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Bionic Power Main Business Overview
13.16.5 Bionic Power Latest Developments
14 Research Findings and Conclusion
*If Applicable.
